Date(s)

25 Nov 2022 - 26 Nov 2022

Program Language

English

Location

United Arab Emirates

Meeting type

Live Meeting

GCC HIV Clinical Forum 2022

Related Enduring Materials

Enduring Materials

Session 1 | Antiretroviral Therapy 2022 - State-of-the-ART Plenary Lectures -

International Guidelines (DHHS / IAS) - Focus on Patients' Needs?

Ghassan Wali, MD, FRCP(C)

King Faisal Specialist Hospital and Research Centre, Saudi Arabia

Early Diagnosis and Same-Day ART

Laura Waters, MD, FRCP

Central & North West London NHS Foundation Trust, United Kingdom

Video

Slideset

Session 2 | Clinical Considerations for Starting and Switching Therapy -

Resistance Considerations When Choosing Optimal Treatment Regimen

Laura Waters, MD, FRCP

Central & North West London NHS Foundation Trust, United Kingdom

Video

Slideset

Pharmacological Considerations When Choosing Optimal Treatment Regimen

Marta Boffito, MD, PhD, FRCP

Chelsea and Westminster Hospital London, United Kingdom

Video

Slideset

Clinical Management of People Living with HIV and Comorbidities (+ CVD)

Jehad Abdalla, MD

Sheikh Khalifa Medical City, United Arab Emirates

Video

Slideset

Clinical Considerations of Aging People Living with HIV

Marta Boffito, MD, PhD, FRCP

Chelsea and Westminster Hospital London, United Kingdom

Video

Slideset

Clinical Case (Focused on Naïve Patient/Test-Treat Setting)

Osama Albaksami, MD

Infectious Diseases Hospital, Ministry of Health, Kuwait

Session 3 | Antiretroviral Therapy in Diverse Populations -

Two-Drug Regimen - Selecting the Right Patient

Sharon Walmsley, CM, MD, FRCPC

University Health Network, Canada

Video

Slideset

Treatment Optimalization in Suppressed PLWH - Is 2DR an Option?

Ahmad Alharbi, MD

King Abdulaziz Medical City, Kingdom of Saudi Arabia

Video

Slideset

Two-Drug Regimen - Sharing Experiences / Real World Evidence

Jürgen Rockstroh, MD

University of Bonn, Germany

Video

Slideset

New Available Options - Switching the Treatment of HIV

Aqeel Saleem, MD

Tawam Hospital / Abu Dhabi Healthcare Company (SEHA), United Arab Emirates

Video

Slideset

Session 4 | Next Challenges in HIV therapy -

Long-Acting Therapeutic Options for HIV Treatment and Prevention: A Review of Clinical Data

Sharon Walmsley, CM, MD, FRCPC

University Health Network, Canada

Video

Slideset

People Living with HIV with Limited Treatment Options

Jürgen Rockstroh, MD

University of Bonn, Germany

Video

Slideset

Defining Healthy Outcomes in HIV

Jameela Al-Salman, MD

Salmaniya Medical Complex, Kingdom of Bahrain

Overview

Welcome

The GCC HIV Clinical Forum 2022 provided an independent scientific program involving the world’s leading experts. It was specifically designed for HIV healthcare professionals in the Gulf region and focuses on optimizing treatment for their patients.

This program featured challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and knowledge-sharing within the HIV-treating community. The program also included networking opportunities for community-building, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.

The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV, involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management. Here, they can also share their clinical experience as well as present results from their ongoing and completed cohorts/research programs.

Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects.

General Information

COVID-19 Update

The GCC HIV Clinical Forum 2022 will be held as a live meeting.

We are available to answer any questions or concerns that you may have about your participation at the GCC HIV Clinical Forum 2022. For more information, please contact Ms. Dagmar Jónasdóttir at dagmar@amededu.com.

To stay updated on developments about this meeting, make sure that you are signed up for our newsletter.

Who Should Attend?

Primary: Medical doctors involved in the management and treatment of people living with HIV in the region

Secondary: Researchers

Tertiary: Healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV.

Meeting Objectives

With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment strategies and options
- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV

Learning Objectives

After participating in the HIV Clinical Forum, participants will be able to:

- Understand the scientific rationale and clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies and drugs
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might most benefit from long-acting injectable regimens
- Gain knowledge on how to optimally integrate injectable drugs into routine clinical care
- Improve their skills in defining and identifying treatment experienced people living with HIV
- Stay informed on new drug options for treatment experienced people living with HIV
- Understand how best to use new treatment options for highly treatment experienced people living with HIV

Practical Information

Venue

The meeting was held at GRAND HYATT DUBAI.

Website: Grand Hyatt Dubai
Address: Sheikh Rashid Road, Dubai, P.O. Box 7978, United Arab Emirates
Phone: T +971 4317 2609 M +971 52 119 7383

In case you have any questions or concerns regarding the venue, please feel free to contact Ms. Natalia Voronina at natalia.voronina@amededu.com.

Certificate of Attendance

A certificate of attendance will be sent by e-mail shortly after the forum meeting.

Disclaimer

This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.

Language

The official language of this meeting is English.

Liability and Insurance

By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Payment and Procedure of Online Registration

The registration fee is waived for all healthcare professionals. Should you need any assistance with registering, please contact Ms. Natalia Voronina at natalia.voronina@amededu.com

Photographs, Audio, and Video Recording

Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.

Committees